4//SEC Filing
Christensen Jamie 4
Accession 0001628280-24-001690
CIK 0001576263other
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 4:38 PM ET
Size
6.6 KB
Accession
0001628280-24-001690
Insider Transaction Report
Form 4
Christensen Jamie
SVP & Chief Scientific Officer
Transactions
- Sale
Common Stock
2024-01-16$59.02/sh−631$37,242→ 155,927 total - Sale
Common Stock
2024-01-16$59.02/sh−966$57,013→ 156,558 total
Footnotes (3)
- [F1]Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 14, 2022.
- [F2]Includes 347 shares acquired under the ESPP Purchase on 05/31/2023 and 42 shares acquired under the ESPP purchase on 11/30/2023.
- [F3]Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 15, 2021.
Documents
Issuer
Mirati Therapeutics, Inc.
CIK 0001576263
Entity typeother
Related Parties
1- filerCIK 0001599324
Filing Metadata
- Form type
- 4
- Filed
- Jan 17, 7:00 PM ET
- Accepted
- Jan 18, 4:38 PM ET
- Size
- 6.6 KB